Search

The integration of artificial intelligence (AI) into healthcare systems has transformed clinical analytics, particularly in improving medication safety through advanced reconciliation processes, structured error taxonomies, and careful deployment strategies. This narrative review examines how AI-driven analytics embedded within clinical infrastructures can reduce medication-related risks in hospital and ambulatory care settings. AI technologies such as natural language processing and machine learning enable automated detection of medication discrepancies by analyzing electronic health records and identifying inconsistencies that may be overlooked by manual review.AI systems also support the classification and prediction of medication errors, including prescribing mismatches and administration failures, allowing clinical decision support systems to identify high-risk prescriptions and support safer prescribing practices. In addition, AI contributes to closed-loop healthcare systems where analytics provide real-time decision support across the data lifecycle, from information ingestion to post-intervention feedback.Despite these benefits, several deployment constraints remain, including data quality limitations, interoperability challenges, and ethical concerns related to bias and governance. These factors highlight the importance of robust system design and transparent AI models to ensure safe and equitable implementation. Furthermore, AI can support standardized error taxonomies and pharmacovigilance through structured analytical frameworks that improve reporting and monitoring of adverse events.Overall, this review positions AI as a central component of adaptive clinical systems capable of strengthening medication safety. However, its effectiveness depends on addressing technical, operational, and regulatory barriers. Continued interdisciplinary collaboration will be essential to refine AI-enabled clinical analytics and support safer, more efficient healthcare systems.

Distribution shifts pose a major challenge for artificial intelligence (AI) deployed in healthcare systems, as models trained on historical or controlled datasets often perform poorly in evolving clinical environments. This narrative review synthesizes current approaches for detecting, adapting to, and classifying failures associated with distribution shifts in AI-driven healthcare analytics. Sources of shift—including changes in patient demographics, imaging protocols, institutional practices, and temporal dynamics—can significantly affect clinical decision support, predictive modeling, and operational analytics.We examine detection strategies based on statistical divergence monitoring and discuss adaptation methods such as domain adaptation and privacy-preserving learning approaches designed to maintain model performance across institutions. Failure modes are organized into core categories, including covariate shift, label shift, and concept drift, with particular attention to healthcare-specific risks such as bias amplification and breakdowns in continuous monitoring systems.From a systems perspective, the review highlights the importance of integrating shift detection with clinical analytics pipelines, governance mechanisms, and explainable AI tools to support safe deployment. We propose an interpretive framework linking data ingestion, model inference, intervention feedback, and oversight processes within healthcare infrastructures. Despite advances in detection and adaptation techniques, real-time operational deployment and standardized failure classification remain significant gaps. Strengthening these areas is essential for developing resilient AI systems capable of maintaining reliability in dynamic healthcare environments.

The rapid integration of artificial intelligence (AI) into healthcare analytics has amplified the need for robust frameworks that govern secondary use of genomic and clinical data while prioritizing patient consent and policy compliance. This conceptual manuscript introduces a novel policy-constrained access control framework designed to facilitate consent-aware analytics in genomic-clinical environments. By embedding dynamic consent mechanisms into data access pipelines, the framework ensures that secondary data utilization adheres to ethical, legal, and institutional policies, mitigating risks associated with unauthorized reuse. We synthesize recent literature on data sharing, privacy protections, and genomic informatics to underscore the framework’s theoretical foundations. Key components include layered access orchestration, policy-enforced query resolution, and feedback loops for consent revocation monitoring. Conceptual formulas are presented to interpret risk propagation in access chains and governance load under varying policy constraints. The architecture promotes interoperability between genomic repositories and clinical systems, fostering trustworthy AI-driven insights without empirical validation. Implications for healthcare stakeholders emphasize enhanced data stewardship, reduced privacy breaches, and scalable secondary analytics. This work advances conceptual discourse on AI-enabled healthcare systems by proposing a governance-centric infrastructure that balances innovation with patient autonomy in secondary data contexts.